Pages that link to "Q33977402"

The following pages link to Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine (Q33977402):

Displaying 18 items.

• The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B (Q27007019) (← links)
• Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus (Q28360714) (← links)
• Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine (Q33206221) (← links)
• Low dynamic state of viral competition in a chronic avian hepadnavirus infection (Q33787127) (← links)
• The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection (Q33787525) (← links)
• Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. (Q33812799) (← links)
• Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. (Q33834863) (← links)
• Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil (Q34330228) (← links)
• Superinfection with woodchuck hepatitis virus strain WHVNY of livers chronically infected with strain WHV7 (Q34992624) (← links)
• Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening (Q35014297) (← links)
• Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection (Q35166065) (← links)
• Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks (Q35751930) (← links)
• Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection (Q36932959) (← links)
• Antiviral resistance and hepatitis B therapy (Q37255008) (← links)
• The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection (Q38618869) (← links)
• Viral resistance in hepatitis B: prevalence and management (Q39429039) (← links)
• Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection. (Q40847895) (← links)
• Down-regulation of hepatitis delta virus super-infection in the woodchuck model (Q92270399) (← links)